Recombinant Peptides Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4114960
- 90 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Recombinant Peptides market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Recombinant Peptides market segmented into
Glucagon
Calcitonin
Others
Based on the end-use, the global Recombinant Peptides market classified into
Oncology
Blood Disorders
Infectious Diseases
Autoimmune Diseases
Others
Based on geography, the global Recombinant Peptides market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Sandoz Pharma
Stada Arzneimittel
Amgen
Hospira
Actavis
Cipla Ltd.
Wockhardt Ltd.
Biocon Ltd.
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RECOMBINANT PEPTIDES INDUSTRY
2.1 Summary about Recombinant Peptides Industry
2.2 Recombinant Peptides Market Trends
2.2.1 Recombinant Peptides Production & Consumption Trends
2.2.2 Recombinant Peptides Demand Structure Trends
2.3 Recombinant Peptides Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Glucagon
4.2.2 Calcitonin
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Oncology
4.3.2 Blood Disorders
4.3.3 Infectious Diseases
4.3.4 Autoimmune Diseases
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Glucagon
5.2.2 Calcitonin
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Oncology
5.3.2 Blood Disorders
5.3.3 Infectious Diseases
5.3.4 Autoimmune Diseases
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Glucagon
6.2.2 Calcitonin
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Oncology
6.3.2 Blood Disorders
6.3.3 Infectious Diseases
6.3.4 Autoimmune Diseases
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Glucagon
7.2.2 Calcitonin
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Oncology
7.3.2 Blood Disorders
7.3.3 Infectious Diseases
7.3.4 Autoimmune Diseases
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Glucagon
8.2.2 Calcitonin
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Oncology
8.3.2 Blood Disorders
8.3.3 Infectious Diseases
8.3.4 Autoimmune Diseases
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Glucagon
9.2.2 Calcitonin
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Oncology
9.3.2 Blood Disorders
9.3.3 Infectious Diseases
9.3.4 Autoimmune Diseases
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sandoz Pharma
10.1.2 Stada Arzneimittel
10.1.3 Amgen
10.1.4 Hospira
10.1.5 Actavis
10.1.6 Cipla Ltd.
10.1.7 Wockhardt Ltd.
10.1.8 Biocon Ltd.
10.2 Recombinant Peptides Sales Date of Major Players (2017-2020e)
10.2.1 Sandoz Pharma
10.2.2 Stada Arzneimittel
10.2.3 Amgen
10.2.4 Hospira
10.2.5 Actavis
10.2.6 Cipla Ltd.
10.2.7 Wockhardt Ltd.
10.2.8 Biocon Ltd.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Recombinant Peptides Product Type Overview
2.Table Recombinant Peptides Product Type Market Share List
3.Table Recombinant Peptides Product Type of Major Players
4.Table Brief Introduction of Sandoz Pharma
5.Table Brief Introduction of Stada Arzneimittel
6.Table Brief Introduction of Amgen
7.Table Brief Introduction of Hospira
8.Table Brief Introduction of Actavis
9.Table Brief Introduction of Cipla Ltd.
10.Table Brief Introduction of Wockhardt Ltd.
11.Table Brief Introduction of Biocon Ltd.
12.Table Products & Services of Sandoz Pharma
13.Table Products & Services of Stada Arzneimittel
14.Table Products & Services of Amgen
15.Table Products & Services of Hospira
16.Table Products & Services of Actavis
17.Table Products & Services of Cipla Ltd.
18.Table Products & Services of Wockhardt Ltd.
19.Table Products & Services of Biocon Ltd.
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Recombinant Peptides Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Recombinant Peptides Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Recombinant Peptides Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Recombinant Peptides Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
